Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print December 19, 2007, doi:10.1212/01.wnl.0000284600.80782.d5)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow CME: Take the course for this article:
Volume 70, Number 5, January 29, 2008
Right arrow Podcast
Right arrow All Versions of this Article:
01.wnl.0000284600.80782.d5v1
70/5/344    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banwell, B.
Right arrow Articles by Pittock, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banwell, B.
Right arrow Articles by Pittock, S. J.
Received April 4, 2007
Accepted May 22, 2007

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders

B. Banwell MD, FRCPC, S. Tenembaum MD, V. A. Lennon MD, PhD, E. Ursell , J. Kennedy , A. Bar-Or MD, B. G. Weinshenker MD, C. F. Lucchinetti MD, and S. J. Pittock MB, MD*

From the Division of Pediatric Neurology and the Research Institute (B.B., E.U., J.K.), The Hospital for Sick Children, University of Toronto, Canada; Department of Pediatric Neurology (S.T.), Hospital de Pediatria Dr. J.P. Garrahan, Buenos Aires, Argentina; Departments of Neurology (V.A.L., B.G.W., C.F.L., S.J.P.), Laboratory Medicine and Pathology (V.A.L., S.J.P.), and Immunology (V.A.L.), Mayo Clinic College of Medicine, Rochester, MN; and The Montreal Neurological Institute and McGill University (A.B.-O.), Montreal, Canada.


* To whom correspondence should be addressed. E-mail: Pittock.Sean{at}mayo.edu.

ABSTRACT

Objective: To determine seroprevalence of neuromyelitis optica (NMO)-IgG in childhood CNS inflammatory demyelinating disorders.

Methods: We analyzed demographic, clinical, and radiologic data in a blinded fashion and assessed serum NMO-IgG status for 87 children: 41 with relapsing-remitting multiple sclerosis (RRMS), 17 with NMO, 13 with monophasic/recurrent optic neuritis (ON), 13 with transverse myelitis, of whom 10 were longitudinally extensive on MRI spine (LETM), and another 3 with LETM in the context of acute disseminated encephalomyelitis (ADEM).

Results: Ten of the 87 children (11%) were seropositive. Eight of 17 with NMO (47%) were seropositive (7 of 9 with relapsing NMO [78%], 1 of 8 with monophasic NMO [12.5%]). Two other children were seropositive: 1 of 5 with recurrent ON and one child with recurrent LETM. No seropositive case was identified among 41 with RRMS (14% of whom had LETM at some point in their clinical course), 8 with monophasic ON, 9 with monophasic LETM, or 3 with LETM in the context of ADEM.

Conclusions: The similar frequency of neuromyelitis optica (NMO)-IgG in both childhood and adult cases of NMO, and its rarity in relapsing-remitting multiple sclerosis, supports the concept that these diseases have a similar pathogenesis in childhood and adulthood. It is noteworthy that none of nine children with monophasic longitudinally extensive transverse myelitis (LETM) was NMO-IgG-seropositive. Furthermore, LETM does not appear to be as predictive of an NMO spectrum disorder in children as it is in adults. Longitudinal studies of larger pediatric LETM cohorts are required to ascertain whether the absence of NMO-IgG is a negative predictor for relapse in this childhood entity.




This article has been cited by other articles:


Home page
Arch NeurolHome page
S. M. Magana, S. J. Pittock, V. A. Lennon, B. M. Keegan, B. G. Weinshenker, and C. F. Lucchinetti
Neuromyelitis Optica IgG Serostatus in Fulminant Central Nervous System Inflammatory Demyelinating Disease
Arch Neurol, August 1, 2009; 66(8): 964 - 966.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
E. M. Yiu, A. J. Kornberg, M. M. Ryan, L. T. Coleman, and M. T. Mackay
Acute Transverse Myelitis and Acute Disseminated Encephalomyelitis in Childhood: Spectrum or Separate Entities?
J Child Neurol, March 1, 2009; 24(3): 287 - 296.
[Abstract] [PDF]


Home page
NeurologyHome page
A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, et al.
CNS aquaporin-4 autoimmunity in children
Neurology, July 8, 2008; 71(2): 93 - 100.
[Abstract] [Full Text] [PDF]


Home page
JWatch NeurologyHome page
Neuromyelitis Optica IgG in Childhood-Onset Demyelinating Diseases
Journal Watch Neurology, June 10, 2008; 2008(610): 4 - 4.
[Full Text]


Home page
Arch NeurolHome page
S. J. Pittock and V. A. Lennon
Aquaporin-4 Autoantibodies in a Paraneoplastic Context
Arch Neurol, May 1, 2008; 65(5): 629 - 632.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Levy, J. Birnbaum, and D. Kerr
Finding NMO: Neuromyelitis optica in children
Neurology, January 29, 2008; 70(5): 334 - 335.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.